Nanomaterials offer unique opportunities to engineer immunomodulatory activity. In this work, we report the Toll-like receptor agonist activity of a nanoscale adjuvant zeolitic imidazolate framework–8 (ZIF-8)...
Jaklenec Group's News
Scientists from the Massachusetts Institute of Technology (MIT) and elsewhere have published a paper in Science Advances that describes a type of nanoparticle for delivering vaccines called a metal organic...
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose...
Vaccines are one of the best scientific discoveries because they prevent the incidence of some of the deadliest diseases. The medical field has been using them to prevent smallpox, tuberculosis, and even cancer. A recent study...
In the heart of Cambridge, Massachusetts, a groundbreaking discovery has emerged from the laboratories of the Massachusetts Institute of Technology (MIT). A team of scientists, driven by curiosity and an unyielding commitment to public health, has unlocked a new...
The National Academy of Inventors recently announced its 2023 class of fellows, which includes four American Society for Biochemistry and Molecular Biology Members: Ana Jaklenec...
Accurate medical recordkeeping is important for personal and public health. Conventional forms of on-patient medical information may compromise patient privacy because they are readily visible to other people. Here, the development of an invisible, temporary, and easily deployable...
The highest professional distinction accorded solely to academic inventors, election to the NAI recognizes individuals who have created or facilitated outstanding inventions that have made a tangible impact on quality of life, economic development, and the...
On Nov. 7, a team from the Marble Center for Cancer Nanomedicine at MIT showed a Washington audience, inlcuding President Joe Biden, several examples of how nanotechnologies developed at the Institute can transform the detection and treatment of cancer...
Dr. Ana Jaklenec featured in the December 2023 Controlled Release Society's (CRS) Newsletter "Tech Update"...
- ‹ Previous
- 3 of 8
- Next ›